August 12, 2025

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Healthcare Innovator with 23.72% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, is capturing investor attention with its innovative approach to spinal disorder treatments and an..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Unpacking a 58.93% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing the attention of investors with an impressive potential upside of 58.93%, as indicated by current analyst ratings. This..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 39% Potential Upside with Robust Revenue Growth

Veracyte, Inc. (VCYT) has become an intriguing player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $2.2 billion,..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring Over 130% Potential Upside in the Biotech Sector

Denali Therapeutics Inc. (NASDAQ: DNLI) stands as a compelling entity in the biotechnology sector, focusing intently on developing therapeutics for neurodegenerative and lysosomal storage diseases. With..

Kymera Therapeutics (KYMR) Stock Report: Biotechnology Firm Offers 60% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a cutting-edge biotechnology firm headquartered in Watertown, Massachusetts, is captivating investor attention with its innovative approach to drug development and a..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 105% Upside in the Biosimilars Market

Alvotech (ALVO), a dynamic player in the healthcare sector, specifically in the drug manufacturing industry for specialty and generic medications, has been capturing investor interest with..

Progyny, Inc. (PGNY) Stock Analysis: Exploring the 27.59% Potential Upside for Investors

Investors keen on healthcare opportunities may find Progyny, Inc. (NASDAQ: PGNY) an intriguing prospect in the fast-growing fertility and family-building benefits sector. With a market capitalization..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech Player with 18.83% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is a burgeoning name in the biotechnology sector, headquartered in Foster City, California. With a focused mission on developing novel therapies..

Xenon Pharmaceuticals (XENE) Stock Analysis: A 61% Potential Upside in Neuroscience Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian-based biopharmaceutical company, is generating buzz among investors, particularly those interested in the rapidly evolving field of neuroscience. With a..

Ascentage Pharma Group Internat (AAPG): Analyzing Growth Potential Amidst a 97.9% Revenue Surge

Ascentage Pharma Group International (AAPG) is garnering significant attention in the biotechnology sector with its impressive 97.9% revenue growth. This clinical-stage biotechnology company, headquartered in Suzhou,..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 52% Upside Potential in Biotech

Investors with a keen interest in the biotechnology sector may want to pay close attention to Vericel Corporation (NASDAQ: VCEL), a commercial-stage biopharmaceutical company that specializes..

NovoCure Limited (NVCR): Potential 149% Upside Awaits Investors in the Medical Device Innovator

As the healthcare sector continues to evolve, NovoCure Limited (NASDAQ: NVCR) stands out as a company at the forefront of medical innovation. Specializing in oncology solutions,..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 23.43% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a leading provider in the healthcare sector, is capturing investor attention with its strong growth potential and a significant upside in..

PTC Therapeutics, Inc. (PTCT)

⚠️ No article content returned.

..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Growth in the Dental Market with a 6.23% Potential Upside

Envista Holdings Corporation (NYSE: NVST) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California,..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring Potential Upside with Gene Editing Innovations

CRISPR Therapeutics AG (CRSP), a pioneer in gene-editing technology, stands at the forefront of the biotechnology industry with its cutting-edge CRISPR/Cas9 platform. With a market capitalization..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Unveiling a 29.73% Potential Upside

For investors eyeing the biotechnology sector, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) presents a compelling opportunity, driven by its advanced pipeline of innovative peptide therapeutics and a..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking a 49.87% Potential Upside

Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector, is drawing investor attention, not just for its innovative medical technologies but also for its..

Arrowhead Pharmaceuticals (ARWR): Biotech’s Hidden Gem with a 154% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is emerging as a captivating prospect within the biotech sector, promising significant growth potential for investors with its current price of..

Privia Health Group, Inc. (PRVA): Analyst Consensus Suggests a 47.71% Upside Potential

Investors looking into the healthcare sector might want to pay close attention to Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the health information..

Search

Funds

August 12, 2025

Search

Funds

August 12, 2025

FTSE 100

Funds